US renews push for COVID boosters as data shows they protect

Only about 13% of U.S. adults so far have gotten a “bivalent” shot that targets the Omicron strain as well as the original coronavirus.

0:52

Gov. Murphy: Review of New Jersey’s COVID-19 response could begin within days

1:04

New study shows long-COVID promise; booster clinic in Ridgewood today

Pfizer study says updated COVID boosters rev up protection

BioNTech and Pfizer begin study to evaluate single dose vaccine against flu and COVID-19

BioNTech and Pfizer announced today the initiation of a Phase 1 study evaluating a single dose mRNA-based combination vaccine candidate against influenza and COVID-19.

The New Normal: How severe could RSV and flu be this year?